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Abstract
Here we describe the design, synthesis and evaluation of the first solid-phase substrates for prolyl oligopeptidase (POP), a
cytosolic serine peptidase associated with schizophrenia, bipolar affective disorder and related neuropsychiatric disorders.
This study seeks to contribute to the future design of a one-bead one-compound (OBOC) peptide library of POP substrates,
based on an intramolecular energy transfer substrate. Unexpectedly, the enzymatic evaluation of the substrates attached on
solid-phase by means of the HMBA linker were cleaved through the ester bond, thereby suggesting an unknown esterase
activity of POP, in addition to its known peptidase activity. By performing multiple activity assays, we have confirmed the
esterase activity of this enzyme and its capacity to process the substrates on solid-phase. Finally, we tested a new linker,
compatible with both the solid-phase peptide-synthesis used and the enzymatic assay, for application in the future design
of an OBOC library.
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Introduction
During recent decades, recognition of the importance of
neuropeptides in the correct functioning of the central nervous
system (CNS) has led to the evaluation of various proteases in the
human brain as therapeutic targets. Among these, prolyl
oligopeptidase (POP, EC 3.4.21.26) is of particular relevance
because of its association with schizophrenia, bipolar affective
disorder and related neuropsychiatric disorders. In 1995, Maes
and collaborators detected a higher activity of the POP enzyme in
patients suffering from these illnesses than in healthy subjects [1].
For years, several research groups have focused on the
development of inhibitors of the porcine POP enzyme. However,
no specific inhibitor is currently in clinical use. Consequently,
intense research effort has been devoted to revealing the basic
structure, ligand binding and kinetic properties of POP [2,3].
In 1998, the three-dimensional structure of porcine POP was
published; it consists of two domains: the peptidase domain and
the non-catalytic structural domain [4]. In 2005, the cloning of
POP from human brain RNA was achieved, and a homology
model of the human POP based on porcine POP structure was
designed [5]. Since then and using the expressed human brain
POP, new inhibitors have been reported, such as berberine [6,7].
These results provide an excellent starting point for the design of a
library of substrates in order to elucidate the connection between
the substrates and the activity of the enzyme for the future design
of efficient POP inhibitors.
During the last decade, combinatorial libraries have received
much attention from the pharmaceutical industry because they
can significantly facilitate the drug discovery process; in particular,
interest in one-bead one-compound (OBOC) peptide libraries has
recently increased.
Here we present the results of the first attempt to design an OBOC
peptide library for the POP enzyme, based on an intramolecular
energy transfer substrate (IFETS) published by Fulop et al. [8]. After
being processed by the enzyme, the compounds lead to the separation
of the intermolecular donor-acceptor pair, thus allowing an increase
in the fluorescence proportionally to the amount of hydrolyzed
peptide. The active substrates will then be physically isolated for
analysis and future structural characterization.
The principle of an OBOC combinatorial library is the synthesis
of many compounds in solid-phase by a ‘‘Mix-Split’’ approach [9].
This methodology presents many copies of the same compound on
a single bead. Each bead contains only one compound and many of
these compound beads are synthesized simultaneously. In order to
use this kind of library for a specific target, the parameters must be
established in order to ensure a good screening methodology, which
includes: the selection of the model compound, with a fluorophore
and a quencher; a proper linker; and the selection of a resin to
immobilize the compound and ensure the proper enzymatic assay,
among other parameters. Here we describe the results we obtained
during the fine-tuning of an OBOC peptide library for POP, based
on a substrate described by Fulop et al. [8]. These results provide the
first step for a future OBOC library.
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Results and Discussion
Model substrate synthesis
The original porcine POP brain substrate described by Fulop et
al. [8] and the two expected fragments from the enzyme processing
were prepared using solid-phase peptide synthesis (SPPS). After
optimizing the synthetic methodology, the compounds were
obtained with purity higher than 90% and were characterized
by HPLC-UV, HPLC-MS and MALDI-TOF MS.
Enzymatic evaluation of the model substrate in solution
Fulop et at. reported that the model substrate was a substrate of
the porcine POP enzyme [8]. In the present study, the substrate
was incubated in 100 mM Na+/K+ phosphate buffer pH 8.0 with
diverse concentrations of the human brain POP and the model
substrate for 1 h at 37uC. The reaction was stopped by heating at
95uC for 5 min to denaturalize the enzyme and then evaluated by
HPLC-UV (Figure 1), MALDI-TOF spectrometry and fluores-
cence. This experiment demonstrated that the compound is also a
human brain POP substrate.
After analyzing the non-autofluorescence of POP at the working
range of wavelengths and characterizing the fluorescence of the two
fragments, we confirmed that quenching occurs via a collision
mechanism. This observation must be taken in consideration during
the design of a future OBOC peptide library [10] as the interaction
between the two groups occurs at a shorter distance range.
Design of the solid-phase analogs
Peptide substrates, such as the model compound, are commonly
used for determining the activity of a proteolytic enzyme in
solution. However, when the substrate is attached to a solid
support, additional concerns must be considered: the interference
of the solid support with the substrate hydrolysis to ensure
sufficient space for the enzyme reaction (usually solved with the
presence of spacer molecules to take the reaction site further away
from the solid support); the need for a specific free terminal end of
the peptide to reach the active site and to be hydrolyzed by the
enzyme (related to the enzymatic mechanism); and the substrate
recognition effect produced by the sequence changes in order to
obtain a fluorescent bead after the hydrolysis.
To design the solid-phase analogs, the structure of the substrate
situated at the active site of the POP enzyme, obtained by Fu¨lo¨p
and coworkers, was considered [8]. The designed analogs are
shown in Figure 2. On the basis of the homology model [5], we
considered necessary the presence of a spacer molecule between
the substrate and the linker necessary to allow the anchored
peptide to enter the active site. A hydrophilic spacer consisting of a
polyethylene glycol, the 8-amino-3,6-dioxaoctanoic acid (abbrevi-
ated as O2Oc), was selected to permit accessibility and
compatibility with the enzymatic assay. To identify the charac-
teristics required for a solid-phase anchored peptide to be a POP
substrate, we designed several peptides.
These peptides were divided into two groups depending on the
peptide end attached to the resin. A number of derivates were
attached to the solid support by the C-terminal end, while the
others were attached by the N-terminal end. In order to design an
OBOC peptide library, the positions of the fluorophore and the
quencher moieties were changed in the C-terminal-anchored
peptides to obtain a fluorescent bead after the hydrolysis of the
substrate by the POP enzyme (Figure 2). The linker on the
polymer was also selected to allow easy peptide sequence analysis
after the enzymatic evaluation compatible with the SPPS.
Moreover, control peptides (not anchored to the resin) for each
anchored analog were also prepared to ensure that changes to the
peptides were not affecting their recognition by the POP enzyme.
Selection of the resin
To select the most appropriate resin for the synthesis and the
following enzymatic assay, three PEG-based resins (Tentagel
Standard, Aminomethyl Chemmatrix and PEGA1900) and two
Figure 1. RP-HPLC Chromatogram of the enzymatic evaluation of themodel substrate. Conditions: lineal gradient of 0–100%MeCN (0.036%
TFA) in H2O (0.045% TFA) in 15 min. Flux of 1 mL/min, in a symmetry column C18 (4.6 mm6150 mm), Waters, 100 A˚, 5 mm, detection at 220 nm.
doi:10.1371/journal.pone.0006222.g001
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control polystyrene resins (Sieber and p-MBHA) were selected.
First of all, we examined the effect of the employed solvents by
measuring the swelling of the selected resins (figure 3). These
measurements showed that PEGA1900 had better swelling
properties than Tentagel S and Chemmatrix resins. In contrast
to polystyrene resins, PEGA1900 showed similar swelling in organic
and aqueous systems, especially when we compare the DMF
where the synthesis will be carried out and the buffer with enzyme
in which the peptide will be assayed. PEGA1900 resin has the best
swelling properties for the purposes of a successful synthesis and
enzymatic evaluation.
Another key factor for the design of an OBOC peptide library is
bead homogeneity. In the future library, each bead will contain a
distinct compound and its fluorescence should depend only on the
nature of the compound, not on the amount of compound on the
bead. Optical microscopy images of the resin swelled in buffer with
the POP enzyme were taken and the beads were characterized in
terms of size and size distribution. These measurements showed
that Tentagel S and PEGA1900 had a more homogenous bead size
than Aminomethyl-Chemmatrix. Finally, the auto-fluorescence of
resins was measured under several light sources. No resin showed
high fluorescence under the working conditions; only a very small
reminiscent auto-fluorescence was detected.
Another crucial feature of the set-up is the capacity of the
enzyme to penetrate the support beads. Previous studies showed
that Tentagel S presents limitations in aqueous solution, where
enzymatic catalysis takes place, as a result of the presence of DVB
as cross-linking agent. In contrast, peptides attached to PEGA1900
are processed by the enzyme in near quantitative yield [11,12].
The evaluation of a model compound with an enzyme of the same
molecular weight as POP, the penicillin acylase, presented no
enzymatic cleavage when Tentagel S was used, while partial
Figure 2. Representation of (a) the model substrate, (b) the C-terminal-anchored analogs and control peptides, (c) the N-terminal-
anchored analogs and control peptides.
doi:10.1371/journal.pone.0006222.g002
Figure 3. Swelling of the resins in five different solvents in mL/gr.
doi:10.1371/journal.pone.0006222.g003
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cleavage was observed using PEGA1900. These observations
demonstrated that PEGA1900 shows better performance in terms
of bio-compatibility than Tentagel S [13].
PEGA resin can take several forms depending on the chain
length, which affects enzyme accessibility. There is evidence that
PEGA beads restrict the penetration of enzyme molecules,
particularly larger ones. Previous studies report that PEGA4000
and PEGA1900 can be used for enzymes with a molecular weight of
up to 120KDa and 60KDa, respectively [14]. Since the enzyme
pores limit its diffusion to the core of the particle, enzyme-
mediated reactions occur only at the surface [15,16]. If the
reaction occurs only at the surface, some entire peptide will remain
in the core of the bead. If this is the case, it could be an interesting
advantage in our case, since, by evaluating the entire peptide in
the positive bead, it will allow us to change more residues of the
peptide in the future OBOC peptide library located in the
fragment expected to be released. We therefore chose to use
PEGA1900 for our purposes.
Synthesis of the analogs
The solid-phase analogs were synthesized by SPPS. To prevent
the premature and undesired removal of the Fmoc-protecting group
of the aN-amino acids by the e–amino of the Lys [17], an orthogonal
protection scheme of the aN-amino acid and the eN-Lysine was used
for the synthesis of the analogs. The orthogonal protection scheme
included Fmoc/tBu chemistry and allyloxycarbonyl (Alloc) protec-
tion and also Fmoc/tBu chemistry and Boc protection. Figure 4
presents a general scheme of the analog syntheses.
The amino group was modified by attaching an appropriate
linker, the 4-hydroxymethylbenzoic acid (HMBA) linker, which is
compatible with Fmoc/tBu chemistry and Boc and Alloc
protection and described to be stable in activity assays [16]. In
Figure 4. General representation for the synthesis of the anchored analogs. (a) C-terminal analogs and (b) N-terminal analogs.
doi:10.1371/journal.pone.0006222.g004
OBOC Methodology for POP
PLoS ONE | www.plosone.org 4 July 2009 | Volume 4 | Issue 7 | e6222
the synthesis of the N-terminal-anchored peptides, succinic
anhydride was coupled after the HMBA linker, thereby allowing
the re-anchoring of the N-terminal analogs and possible cleavage
in order to identify the compounds.
The C-terminal-anchored analogs were directly synthesized in
PEGA1900 resin containing the HMBA linker, while the control
peptides of the C-terminal-anchored analogs were synthesized in
polystyrene resin. Usually SPPS proceeds from the C-terminal to N-
terminal, because previous attempts in the opposite direction
encountered inherent problems that limited its general application
[18–22]. Consequently, the N-terminal-anchored peptides were
synthesized by using polystyrene, cleaved and re-anchored by the
N-terminal to the PEGA 1900 resin. If the future library is designed
based on N-terminal peptides, then a similar synthetic strategy to Yao
et al. would be used to obtain the free carboxyl end peptides [18].
After optimizing the methodology, the peptides were obtained in
good purity (no purification was required) and yield. For instance,
Figure 5 shows the analog synthetic methodology containing two
spacers before being anchored by the N-terminal side.
After the synthesis, control cleavages of all the compounds were
analyzed by HPLC-UV and MALDI-TOF. All compounds were
obtained in good purity (Figure 6).
If the POP enzyme processes the anchored analogs, only one of
the two fragments will be released, thereby allowing its detection in
the solution by HPLC-UV. The fragments generated by the three
analogs in each group, the N-terminal or the C-terminal groups,
were the same as shown in Figure 7. And the fragment generated
from the N-terminal analogs will be the same as one of the
fragments generated by the model substrate. Consequently, only
the fragment generated by the C-terminal analogs was synthesized.
Enzymatic evaluation of the analogs
All the control peptides (peptides in solution) were incubated
under the same conditions and following the same methodology as
the model substrate; 90 mM of the control peptide with a range of
concentrations of the POP enzyme in Na+/K+ phosphate buffer
pH 8.0 (100 mM) during 15 min, 30 min, 1 h and 3 h at 37uC.
Although the peptide sequences presented modifications
compared to the model substrate, analyses by HPLC-UV and
HPLC-MS confirmed that the control peptides were also POP
substrates. This result indicated that the sequence modifications
did not affect the recognition of the peptides as POP substrates.
The peptides attached to the solid support, PEGA1900 resin,
were incubated with the POP enzyme by using Sigma Corning
Spin-X centrifuge tube filters, as shown in Figure 8. After
conducting the activity assay, the solution and the beads were
separeated by centrifugation. After a treatment to remove the POP
enzyme, desalt and pre-concentrate the peptide, the filtrate was
analyzed by HPLC-UV and MALDI-TOF or HPLC-MS. Finally,
the peptides attached on the bead were cleaved from the resin and
analyzed by MALDI-TOF or directly analyzed under a fluores-
cence microscope.
The anchored analogs at a concentration of 300 mM were
incubated with a range of human POP concentrations and times
(usually longer incubations than the control peptides) in Na+/K+
phosphate buffer pH 8.0 (100 mM) at 37uC. If the enzyme was
processed the anchored analogs, this methodology would permit
the detection of the fragment containing the fluorophore in the
bead and the fragment containing the quencher in the solution.
Unexpectedly, the solution analysis detected the presence of both
fragments, thereby suggesting the processing of the substrates by
POP but also cleavage from the solid-phase. But the question
raised was whether the compounds were processed by the enzyme
and then released from the solid-phase or whether they were
cleaved and then processed by the enzyme.
If the POP had processed the compounds attached on solid-
phase, then the beads could still contain some attached fragment.
After incubating the substrates on solid-phase with POP, several
beads were placed in a MALDI plate and treated with NH3
vapour and analyzed by MALDI-TOF. Another fraction of beads
Figure 5. RP-HPLC Chromatogram of an analog peptide (two spacers) before being anchored by the N-terminal side. Conditions:
lineal gradient of 0–100% MeCN (0.036% TFA) in H2O (0.045% TFA) during 15 min. Flux of 1 mL/min, in a symmetry column C18 (4.6 mm6150 mm),
Waters, 100 A˚, 5 mm, detection at 220 nm.
doi:10.1371/journal.pone.0006222.g005
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were cleaved with NaOH and analyzed by HPLC-UV and
HLPC-MS. The fragment was not detected. Therefore, we could
not confirm whether the POP was processing the fragments on
solid-phase or in solution.
To analyze whether the medium was cleaving the peptides from
the resin, the same assays were conducted at different pHs (6, 7
and 8) and incubation times with and without POP. No cleavage
of the peptide was observed in the absence of the enzyme, thereby
demonstrating that the media was not cleaving the peptides from
the solid support.
To determine whether something present in the POP media was
cleaving the peptide, POP pre-incubated with the ZPP (z-prolil
prolinal), a potent POP inhibitor of the enzyme, was assayed. No
cleavage in the presence of the inhibitor was detected. The
incubation of the solid-phase substrate and the fragment generated
by POP in the presence of the entire peptide was conducted and
Figure 6. Purities and HPLC elution times in a lineal gradient 0–100% MeCN-H20 (15 min), and MALDI-TOF MW of the synthesized
peptides. Control cleavages are also reported for the peptides synthesized or reanchored into PEGA1900 resin.
doi:10.1371/journal.pone.0006222.g006
Figure 7. General scheme of the peptides processed by the POP enzyme and the fragments generated. (a) Model substrate (b) C-
terminal-anchored peptides (c) N-terminal-anchored peptides.
doi:10.1371/journal.pone.0006222.g007
Figure 8. Scheme of the activity assay preparation and analysis of the anchored analogs.
doi:10.1371/journal.pone.0006222.g008
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no cleavage was observed (to discard the self-cleavage produced by
the fragments generated). These results suggested that POP acted
as an esterase, in addition to its known peptidase activity.
To confirm the esterase activity of POP and its capacity to
process the analog peptides on solid-phase, we synthesized and
evaluated new solid-phase peptides. The new derivates were C-
terminal-anchored analogs directly bound on solid-phase (without
a linker), as shown in Figure 9a. These derivates were not intended
for the design of a future library, as they could not be cleaved for
evaluation, but were used only to test this hypothesis.
After the enzymatic assay, the solution was analyzed by HPLC-
UV and MALDI-TOF analysis (Figure 8) showing the presence of
the only expected fragment. These results were also supported by
the bead fluorescence analysis (Figure 10). The fluorescence of the
fluorescent fragment synthesized directly on solid-phase (Figure 9b)
was compared with the fluorescence of the beads after the
incubation with the enzyme and the beads without incubation (see
Figure 10). These experiments confirmed the esterase activity of
POP and also corroborated the capacity of POP to process the
substrates bound on PEGA1900 resin by the C-terminal end.
Moreover, our results demonstrated that POP can process the
substrates on solid-phase without the need of spacers, thereby
simplifying the future design of an OBOC peptide library and also
showing the capacity of POP to penetrate the PEGA1900 resin.
These results confirmed the incompatibility of the HMBA linker
in our system with the POP enzymatic assay. Consequently, a
distinct linker will be necessary for the future design of an OBOC
peptide library (Figure 11). We present the initial results on the use
of the photolabile linker (PLL), by using the Fmoc-4-[4-(1-
aminoethyl)-2-methoxy-5-nitrophenoxy]butyric acid (Fmoc-photo
labile linker; Fmoc-PLL) [23]. The linker, which presents no ester
bonds, was tested with the peptide shown in Figure 12.
The peptide was based on the C-terminal side analog using the
PLL linker to bond to the resin (no spacers were used). After the
enzymatic evaluation, only the expected fragment was present in
the solution, as shown by HPLC-UV and MALDI-TOF analyses.
These results confirmed the synthetic and enzymatic biocompat-
ibility of the new linker.
Conclusions
We have demonstrated that the porcine POP substrate
described by Fulop et al. is also a human POP substrate. We have
characterized this porcine POP substrate for the design of an
OBOC peptide library for the human POP enzyme; this
represents the first attempt to immobilize a POP enzyme substrate
in solid-phase. After the design, synthesis and evaluation of the
analogs of this substrate, our results confirmed that the changes in
the sequences did not interfere in the recognition by the enzyme.
However, the solid-phase analogs were cleaved from the solid
support during the enzymatic evaluation. Our enzymatic analyses
confirmed that the cleavage was not caused by the media, the pH
or the generated fragments, thereby suggesting that the POP
enzyme also acts as an esterase. By directly attaching the substrate
to the resin, we proved the esterase activity of the POP enzyme
and the capacity of the POP enzyme to process the substrates on
solid-phase without the need of spacers on PEGA1900 and
attaching them by the C-terminal end.
Our study demonstrates that the HMBA linker, which was used
to connect the peptide with the solid support by an ester bond,
cannot be used in this system. The design of such a peptide library
will require the use of a distinct linker system that is compatible
with the SPPS and the enzymatic assay. A test was also conducted
with the PLL linker and showed its compatibility with the synthetic
methodology and the enzymatic assay. This linker can therefore be
considered for the future design of an OBOC library for the POP
enzyme.
Materials and Methods
Reagents and instrumentation
Protected amino acids and other residues for SPPS were
purchased from Iris Biotech GmbH, Anaspec Inc., Aldrich,
Luxembourg Industries and Calbiochem-Novabiochem AG.
Handles were supplied by Calbiochem-Novabiochem AG and
Merck; and resins from Polymer Laboratories, Rapp Polymere
GmbH, Calbiochem-Novabiochem AG, Matrix Innovation and
CBL Patras. PyBOP and TBTU were supplied by Iris Biotech
GmbH, DIEA was supplied by Merck and DIPCDI was obtained
from Fluka. DMAP was acquired from Acros Organic, HOBt
from S.D.S., Applied Biosystems supplied PyAOP and Meldal-
Chemy S.L. the HOAt. Piperidine was acquired from SDS and a-
ciano-4-hydroxycinnamic acid (ACH) from Aldrich. Fmoc-4-[4-(1-
aminoethyl)-2-methoxy-5-nitrophenoxy]butyric acid was supplied
by Iris Biotech GmbH.
Acetic anhydride, ninhydrin and phenylsilane were purchased
from Fluka. Triethylamine was obtained from Alta Aesar and
succinic anhydride from Merck. Sodium hydroxide was obtained
from Panreac Quimica S.A. Monobasic potassium phosphate and
dibasic sodium phosphate were purchased from Sigma-Aldrich.
Nylon filters of 0.45 mm and PVDF filters of 0.45 m were
obtained from Millipore. Syringes of 1 mL, 2 mL, 5 mL, 10 mL,
20 mL and 50 mL were purchased from BD Discardit II and BD
Plastikpack. Falcons were obtained from Discardir TT and
Deltalab, respectively. Solvents for peptide synthesis (DMF,
DCM) and RP-HPLC (MeCN, MeOH) were obtained from
SDS. Trifluoroacetic acid was supplied by Fluorochem. Ammonia
was purchased from Aldrich, THF from SDS and acetone and
ethanol from Panreac. Tert-butyl methyle oxide was obtained
from SDS, hydrochloric acid from Scharlab and acetic acid from
Riedel-de Hae¨n.
Buffers for the activity assays were prepared by using a magnetic
shaker from IKA, RCT basic and a pHmeter, Crison, MicropH
2002 - Crison 52-01. Two balances were used in the different
stages of the study: Mettler Toledo, AB-S (0.1 mg) and PB-S
(0.01 mg).
Centrifugation was carried out by a Beckmann Coulter, Allegra
21 R and a Heidolph Unimax 1010 shaker. A spectrophotometer
Figure 9. Representation of the peptides used to confirm the
esterase activity and capacity to process on solid-phase. (a) C-
terminal-anchored analogs directly bounded on solid-phase. (b) C-
terminal control peptides for the fluorescence assay directly bounded
on solid-phase.
doi:10.1371/journal.pone.0006222.g009
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UV-Vis Shimadzu, model UV mini-1240, was used to quantify the
Fmoc deprotections. The micropipettes used were Gilson, Pipet-
man, P2, P20, P200, P1000. The water was obtained from a Milli-
Q A10 system (Millipore).
The rotary evaporator was a Helidolph, Laborota 4003 with
Vacuum pump Vacubrand, MZ 2C. Two incubators were used:
Camlab Microtherm and Koxke. Finally, the lyophilizer was a
Virtis 12EL and the speed-vac an eppendorf concentrator 5301.
HPLC chromatograms were recorded on a Waters model Alliance
2695 with Photodiode array detector 996 from Waters (Waters,
Milford, USA) using a Symmetry C18 column
(15064.6 mm65 mm, 100 A˚, Waters) and a 717 Waters automat-
ic injector, with a software Millenium version 4.0. Solvents were
H2O (0.045% TFA) and MeCN (0.036% TFA), previously passed
through a Millipore system with a filter of 0.45 mm, and samples
were previously passed through a 0.45-mm filter. The working flow
was 1 mL/min.
Some of the initial compounds were purified in an HPLC semi-
preparative Waters 600 with Dual absorbance detector Waters
2487 (Waters, Milford, USA), with a Symmetry C18 column
(100630 mm65 mm, 100 A˚, Waters), which also incorporates a
Waters 2700 automatic injector and a Waters Fraction Collector
Figure 10. Fluorescence microscope images of the peptides shown in figure 8. The images were taken at the excitation wavelength range
of 360/40 nm and emission wavelength range of 420/40 nm. Peptides not assayed with the POP enzyme: (a) NH2FGK(Abz)A-PEGA1900 (b)
NH2FGK(Abz)O2Oc-PEGA1900 (c) NH2FGK(Abz)(O2Oc)2-PEGA1900 (d) NH2F(p-NO2)GFGPFGK(Abz)A-PEGA1900 (e) NH2F(p-NO2)GFGPFGK(Abz)O2Oc-
PEGA1900 (f) NH2F(p-NO2)GFGPFGK(Abz)(O2Oc)2-PEGA1900. Images of the peptides (d) to (f) after the assay with the POP enzyme are shown in
Figures (g) to (i). Fluorescence controls are (j) NH2-Abz-PEGA1900 (positive control) and (k) PEGA1900 (negative control).
doi:10.1371/journal.pone.0006222.g010
OBOC Methodology for POP
PLoS ONE | www.plosone.org 8 July 2009 | Volume 4 | Issue 7 | e6222
II. The system was controlled by the software MassLynx 3.5.
Solvents were H2O (0.1% TFA) and MeCN (0.05% TFA),
previously passed through a Millipore system with a filter of
0.45 mm, and samples were previously passed through a 0.45-mm
filter. The working flow was 10 mL/min.
Mass spectra were recorded on a MALDI Voyager DE RP
time-of-flight (TOF) spectrometer (PE Biosystems, Foster City,
CA, USA), by using a N2 laser of 337 nm. Sample preparation
consisted of mixing 1 mL of the sample with 1 mL of the MALDI
matrix (ACH). Then, 1 m L of this mix was dropped on the
MALDI plate and dried by air. The matrix consisted of a solution
of a-ciano-4-hydroxycinnamic acid (ACH) of 10 mg/mL in
MeCN:H2O (1:1) with 0.1% TFA.
The HPLC-MS consisted of a HPLC Waters model Alliance
2796, a Water 2700 automatic injector, UV/Vis Dual absorbance
detector Waters 2487 and a ESI-MS model Micromass ZQ, with
the software Masslynx version 4.0 (Waters, Milford, USA). This
system used a Symmetry C18 column (15063.9 mm65 mm,
300 A˚, Waters). Solvents were H2O (0.1% formic acid) and
MeCN (0.07% formic acid), previously passed through a Millipore
system with a filter of 0.45 mm, and samples were also previously
passed through a 0.45 mm filter. The working flow was 1 mL/min.
Fluorescence was measured using a Jasco-J810 CD Spectropo-
larimeter. For these measures, the system incorporated a JASCO
Peltier for the control of the temperature and a monochromator
FMO-427 for the measurement.
After optimizing the synthetic methodology, the last syntheses
were conducted using the automatic synthesized 433A, Applied
Biosystems.
HPLC chromatograms for the amino acids analysis were
recorded on a Waters model 600 Controller with Photodiode array
detector 2487 (Waters, Milford, USA) and a 717 plus Waters
automatic injector, with the software Millenium version 4.0.
General protocol for solid-phase synthesis
In all cases the synthesis was conducted with L-amino acids.
Mostly, solid-phase peptide elongation and other solid-phase
manipulations were done manually in polypropylene syringes,
each fitted with a polyethylene porous disk. However, after
optimizing the synthetic methodology, analogs were synthesized
automatically. Solvents and soluble reagents were removed by
suction. Washings between synthetic steps were carried out with
DMF (561 min) and DCM (561 min) using 5 mL of solvent/g
resin each time. During couplings the mixture was allowed to react
with intermittent manual stirring and in some cases mixing was
conducted using a shaker.
SPPS using Fmoc/tBu strategy
Synthesis of C-terminal amide peptides was carried out by using
Sieber amide resin (0.71 mmol/g.). Peptides with an acid group at
the C-terminal side were synthesized using 2-Chlorotrityl resin,
which presented an initial substitution of 1.5 mmol/g. This
substitution was reduced by the partial incorporation of the first
protected amino acid until 0.5–0.7 mmol/g. Finally, anchored
peptides or re-anchoring of the peptides were produced in
PEGA1900 resin (0.2 mmol/g).
All the peptides were synthesized using the Fmoc/tBu strategy,
which allows the incorporation of amino acids with protected
lateral chains in a future OBOC peptide library.
Attachment of the first amino acid to 2-Chlorotrityl resin
The first amino acid coupling over the 2-Chlorotrityl resin was
carried out by adding 0.5 eq. of Fmoc-amino acid and 10 eq. of
DIEA in DCM, and mixing during 80 min. The non-reacted
positions were capped with MeOH (1 mL/g. resin) by mixing
during 10 min. After washing the resin with DCM (561 min) and
Figure 11. Representation of the linker system used in the (a) C-terminal analogs (b) N-terminal analogs.
doi:10.1371/journal.pone.0006222.g011
Figure 12. Representation of the peptide bound to PEGA1900 resin using the PLL linker (drawn in green).
doi:10.1371/journal.pone.0006222.g012
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DMF (561 min), the Fmoc group was removed by piperidine 20%
DMF and quantified, which allowed the coupling quantification.
Attachment of the first amino acid to Sieber resin
Sieber resin is commercially sold in Fmoc-protected form.
Removal of the Fmoc group was carried out after swelling the
resin in DCM (561 min) and DMF (561 min) by treatment with
20% piperidine in DMF (161 min followed by 2610 min). After
washing the resin with DCM (561 min) and DMF (561 min), the
Ninhydrin or Kaiser test [24] was carried out to ensure the
deprotection of the resin.
Initial conditioning of the PEGA 1900 resin
The PEGA1900 resin was conditioned by solvating in MeOH
(5 min.), washing with DCM (1061 min) followed by acid
treatment (DCM with TFA 1%, 1061 min) and neutralization
(DCM with DIEA 5%, 1061 min). Finally the resin was washed
with DCM (1061 min) and DMF (1061 min).
Removal of the Fmoc ((9-fluorenylmethyl) carbamate)
group
Fmoc group was removed after swelling the resin in DMF by
three treatments of the resin with 20% piperidine in DMF (3–
4 mL/g resin): the first of 1 min and the last two of 10 min. The
resin was then washed with DMF (1061 min) and DCM
(1061 min).
Removal of the Boc (tert-Butoxycarbonyl) group
Boc group was removed manually by repeated treatments of the
resin with TFA 55%(v/v) in DCM. In many cases, this step was
conducted at the same time that the peptide was cleaved from the
Sieber resin because only a 2% TFA in DCM was necessary for
the cleavage.
Removal of the Alloc (allyloxycarbonyl carbamate) group
Removal of the Alloc-protecting group was achieved under
argon atmosphere in anhydride CH2Cl2 in the presence of the
scavenger phenylsilane (10 eq.) with Pd(PPh3)4 (0.1 eq.)
(2615 min). Next, the resin was washed with DCM (561 min)
and DMF (561 min), followed by a solution of sodium
diethylditiocarbamate 0.02 M in DMF (2630 min) to remove
the remaining palladium.
Coupling methodology
The general procedure for the coupling of a protected amino
acid (3 or 4 eq.) was the following: a-protected amino acid (3 eq. or
4 eq.), TBTU (3 eq. or 4 eq.) with DIEA (6 or 8 eq.) in DMF (1–
3 mL/g resin). The mixture was left to react with intermittent
manual stirring for 75–90 min. Finally, the solvent was removed
by filtration, and the resin was washed by using DMF (1061 min)
and DCM (1061 min). The extent of the coupling was checked by
using the Ninhydrin [24], Chloranil [25] or De Clercq [26] tests
(depending on the nature of the amino acid group).
Special couplings were conducted for different residues, as it is
following described. Coupling onto proline residue was always
carried out by PyBOP/HOAt/DIEA (3:3:9:9 equiv. or 4:4:12:12
equiv.) in DMF. Coupling of Abz was carried out by using Fmoc-
Abz-OH/PyBOP/HOAt/DIEA (4:4:12:12 equiv.) in DMF.
Coupling onto the O2Oc spacer was conducted by using Fmoc-
O2Oc-OH/PyAOP/DIEA (4:12:12 equiv.) in DMF. The coupling
of the first amino acid onto the HMBA linker attached to PEGA
resin was carried out by 1-mesityl-sulphonyl-3-nitro-1,2,4-triazole
(MSNT) in the presence of N-Methyl imidazole (MeIm) and the
Fmoc-AA-OH in argon atmosphere (2.5:2.35:2 equiv.) [14].
Coupling of the linkers to PEGA1900 resin
The method used for the incorporation of the handle HMBA to
the PEGA was to dissolve the handle HMBA (3 eq.) in DMF/
DCM. Next, TBTU/DIEA (2.85:6 equiv.) were added and mixed
for 3 min. The mixture was added to PEGA resin (already
conditioned) and was kept at room temperature for 4 h with gentle
shaking. Although, the method describe by Meldal [19] included
two couplings, the coupling yield was increased with an additional
third coupling. After washing with DMF followed by DCM, the
Nynhydrin test [24] and the alcohol test [25] were conducted to
ensure the good coupling.
In the synthesis of the N-terminal anchored peptides, after the
HMBA linker, the succinic anhydride was also coupled by using
DIEA (261 h). For the optimization of the anchoring protocol the
N-1-Fmoc-1,5-diaminopentane-HCl was used as a simulation of
the future peptide, which would allow the quantification of the
coupling methodology based on the removal of the Fmoc group.
The peptides were coupled by using PyBOP/HOAt/DIEA
(5:5:7.5 equiv.)
Cleavage from the resin and work-up
After the last residue coupling and control test, the resin was
washed with DMF (561 min.) and DCM (561 min). Next, the
control peptides were cleaved by using a cleavage cocktail (2 mL/
100 mmoles of peptide), which depended on the resin and the
remaining protecting groups. Cleavage of the control peptides
from Sieber amide resin was accomplished by using 3% TFA in
DCM (5610 min) [22]. While, cleavage of the control peptides
(without protecting groups) from 2-Chlorotrityl resin was accom-
plished by using 2% TFA in DCM (5610 min).
Cleavage of the control peptides (containing the Boc-protecting
group) from Sieber amide resin was accomplished by treating the
resin with 55% TFA in DCM. After the cleavage, the filtrates were
collected and evaporated under N2 and work-up with tert-
butylmethylether anhydrous. After centrifugation at 4uC and
4000 rpm during 5 min and removal of the supernatant, the
peptide was solved in H2O/MeCN (1:1) and lyophilized. Finally,
the peptides were characterized by HPLC and MALDI-TOF
Spectrometry.
Cleavage of the peptides from PEGA1900 resin with HMBA
linker
After the synthesis, a control cleavage of the analogs attached by
the C-terminal and the N-terminal to PEGA resin was conducted
in order to analyze them by HPLC and MALDI-TOF. In this
case, the cleavage cocktail was 0.01 N NaOH and cleavage was
carried out for 2 h with automatic shaking [19]. The mixture was
filtered and the solution was neutralized with 0.01 N HCl and
lyophilized. The peptide was solved in H2O/MeCN (1:1) and
analyzed by HPLC and MALDI-TOF.
After the enzymatic assay, the positive beads were placed on the
MALDI plate and the peptide was cleaved using ammonia/THF
vapor for 24 h. Then, 1 mL of MeCN/H2O 1:1, with 0.5% TFA)
was added to each spot for cleaning. After evaporation, each spot
was treated with 1 mL of AcOH/H2O/TFA (3:4:3), and the
solvent was evaporated again. Finally, the MALDI matrix,
consisting of a solution of MeCN/H2O/TFA/a-cyano-4-hydro-
xycinnamic acid (2 mg/mL) (49.5:49.5:0.5:0.5 equiv.), was
deposited on each spot and the plate was then analyzed by
MALDI-TOF Spectrometry [24].
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Cleavage of the peptides from the photolabile linker
Photocleavage of the peptides attached to the resin using the
photolabile peptide was carried out by using a UV lamp of 230 V,
50 Hz at a wavelength of 365 nm during 3 h.
Peptide purification
Some of the peptides were purified by reverse phase HPLC at
semi-preparative scale. The purification conditions were first
optimized by the RP-HPLC at analytical scale. The crude product
was purified using a Symmetry C18 column (100630 mm65 mm,
100 A˚, Waters) with a flow of 10 mL/min and the detection was
carried out at 220 nm. The collected fractions were analyzed by
HPLC at analytical scale and the pure ones were mixed and
lyophilized.
Study of the resins
To study the effect of the distinct solvents, the swelling capacity
of the five amino functionalized resins were measured by swelling
the resins with diverse solvents ordered by increasing polarity:
DCM, DMF, MeOH, water and Na+/K+ phosphate buffer with
POP enzyme. The degree of swelling was measured by weighing a
known amount (50 mg) of each resin in a syringe. Each resin was
then swollen in DMF (1061 min), incubated with that solvent for
5 min and the solvent was then removed without suction. Finally,
the volume was measured. These operations were repeated for
each solvent and the swelling in mL/g was calculated.
To determine the bead size and homogeneity of the resins, the
five resins were swelled in Na+/K+ phosphate buffer 100 mM with
the POP enzyme and optical microscopy images were taken using
an Optical Microscope Nikon Eclipse TS 100 and a Digital
camera Cooled MDC Nikon. The diameter of 100 beads from
each kind of resin were measured and treated statistically. To
determine whether the resins were auto fluorescent, the five resins
were swelled in Na+/K+ phosphate buffer 100 mM with the POP
enzyme and were analyzed by fluorescence microscopy Leica
DMRB with distinct light sources to ensure that the bead itself was
not auto fluorescent.
Conditions for the activity assay in solution
The conditions for the activity assays were 100 mM of Na+/K+
phosphate buffer pH 8.0, at several POP concentrations (from
0.5 ngr/mL to 1.35 ngr/mL) and substrate concentrations of 50
or 90 mM. The incubation was carried out during 1 h at 37uC and
the reaction was stopped by heating at 95uC for 5 min.
Human POP was obtained by expression in E. coli, and
subsequent affinity purification using a His tail fusion [7]. POP
stock solutions were prepared at a concentration of 200 ngr/mL in
Tris HCl 50 mM pH 8. Stock solutions for the substrate were
prepared in H2O : MeCN (1:1, v/v) for each peptide, and the
activity buffer was prepared with Na2HPO4 and KH2PO4 until
pH 8 was reached.
Conditions for the activity assay in solid-phase
The conditions for the activity assays were 100 mM of Na+/K+
phosphate buffer pH 8.0, at several POP concentrations (from
0.5 ngr/mL to 1.35 ngr/mL) and substrate concentrations of
300 mM. The incubation was carried out for 10 min, 20 min,
30 min, 1 h, 2 h, and 3 h at 37uC and the reaction was stopped by
centrifugation (separating the solution and the solid phase).
Activity assay and analysis of the analogs in the presence
of a POP inhibitor
In this experiment, to study the effect of POP and the POP
media, Z-pro-prolinal inhibitor (ZPP) was used to inhibit the
enzyme. ZPP is a commonly used reversible and potent inhibitor
[7]. ZPP was purchased from Biomol Research laboratories Inc.
and dissolved in DMSO at 100 mM. To ensure the inhibition of
the enzyme, 10 eq. of the inhibitor versus the POP enzyme were
used (concentrations were previously tested in other systems). After
pre-incubating the POP with 20 eq. of inhibitor during 15 min,
the substrate was added and incubated for 30 min at 37uC. The
reaction was stopped by centrifugation or heating depending on
the substrate, and MeCN was added to the samples, which were
centrifuged and lyophilized. Finally, the samples were dissolved in
H2O/MeCN and analyzed by HPLC-UV spectrum.
Optical microscopy measurements of resin beads
The size homogeneity of the resin beads was determined by
taking optical microscopy images with a Nikon Eclipse TS 100
optical microscope and a Digital camera Cooled MDC Nikon, and
measuring the diameter of the beads.
Fluorescence microscopy images and cleavage of the
peptides from PEGA1900 resin containing the photolabile
linker
Microscopy fluorescence images of the resin and the peptides
anchored to the resin were carried out with a fluorescence
microscopy Leica DMRB using a Hg vapor lamp and a
stereoscopic fluorescence microscope Leica MZFLIII. The images
were taken with a Digital camera Cooled CCD Micromax, with
RTE 782-Y format, 7826580 pixels, cooled until 215uC by a
system of pelters and using the excitation filter of 360/40 nm and
emission filter of 420/40 nm.
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